TITLE

PAREXEL EXPANDS RELATIONSHIP WITH SYNCHRON IN INDIA

PUB. DATE
May 2008
SOURCE
Worldwide Biotech;May2008, Vol. 20 Issue 5, p3
SOURCE TYPE
Trade Publication
DOC. TYPE
Article
ABSTRACT
The article reports on the expansion of the minority interest of Parexel International Corporation in the clinical pharmacology business of Synchron Research in Ahmedabad, India. The sale of a bioanalytical laboratory in Poitiers, France to a subsidiary of Synchron, Synexel Research International was also announced by the company. The company's ownership in the Ahmedabad Phase I business increased to 31.0 percent under the terms of the agreement.
ACCESSION #
31784379

 

Related Articles

  • Parexel expands ownership in India firm.  // Medical Device Daily;4/7/2008, Vol. 12 Issue 67, p8 

    This article reports on the expansion of ownership of Parexel International in the clinical pharmacology business of Synchron Research of India. The ownership interest of Parexel in the business has increased from 19.5 percent to 31 percent. Parexel opened an office in Hyderabad to offer clients...

  • Parexel launches post-approval regulatory outsourcing service to leverage strategic alliances with sponsors. Korieth, Karyn // CenterWatch Weekly;3/24/2014, Vol. 18 Issue 12, p1 

    The article discusses the outsourcing service offered by the global contract research organization (CRO) Parexel International Corp. which focuses on the maintenance of the postapproval regulatory documents needed by pharmaceutical companies when marketing their drugs worldwide.

  • A Light at the End of the R&D Pipeline. Shapiro, Marissa // Applied Clinical Trials;Oct2008, Vol. 17 Issue 10, p18 

    The article reports on the data published in the "U.S. Drug Approval Trends and Yearbook 2008/2009" by Parexel International Ltd. It indicates an increase in the marketing applications for new molecular entities (NMEs) which offers the best measure for true drug development outputs. It also...

  • in brief.  // Pharmaceutical Technology Europe;Sep2004 Supplement, Vol. 16, p9 

    This article provides news briefs related to pharmaceutical companies. U.S.-based Parexel Inc., a global biopharmaceutical outsourcing organization, has entered into a strategic collaboration with Synchron Research Services, a contract research organization based in Ahmedabad, India. As part of...

  • CROs and Innovative Leadership. Roth, Gil Y. // Contract Pharma;May2013, Vol. 15 Issue 4, p82 

    An interview with Josef von Rickenbach, chairman and chief executive officer of PAREXEL International Corp., is presented. He states that their company has grown important in biopharmaceutical development area. He says that clinical research outsourcing which is the core of their business still...

  • PAREXEL International Corporation. SWOT Analysis.  // PAREXEL International Corporation SWOT Analysis;Apr2012, p1 

    A SWOT analysis for the PAREXEL International Corporation is presented.

  • PAREXEL International Corporation.  // Pharmaceutical Executive;Dec97 Special Issue, Vol. 17, p66 

    Profiles Waltham, Massachusetts-based PAREXEL International Corp. Internet address; Number of employees; Annual worldwide sales; Company description; Markets served; Major products and services.

  • PAREXEL International Corporation Medical Marketing Services Unit.  // Pharmaceutical Executive;Dec97 Special Issue, Vol. 17, p68 

    Profiles Alexandria, Virginia-based PAREXEL International Corp. Medical Marketing Services Unit. Number of employees; Markets served; Major services.

  • Bigger bigger. Jaquiss, Ian // Pharmaceutical Executive;Apr98, Vol. 18 Issue 4, p104 

    Reports that Parexel has broadened its global competitive position with several acquisitions. List of companies acquired by Parexel.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics